Larvol Delta - Ipsen-and-Biomunex-announce-exclusive-global-licensing-agreement-for-rstinclass-MAIT-cell-engager-in-immunooncology

BMX-502 - Biomunex

https://www.globenewswire.com/news-release/2024/12/03/2990251/0/en/Ipsen-and-Biomunex-announce-exclusive-global-licensing-agreement-for-first-in-class-MAIT-cell-engager-in-immuno-oncology.html

Dec 3, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next